Profound Medical Corp. (PROF)
PROF Stock Price Chart
Explore Profound Medical Corp. interactive price chart. Choose custom timeframes to analyze PROF price movements and trends.
PROF Company Profile
Discover essential business fundamentals and corporate details for Profound Medical Corp. (PROF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
29 Oct 2019
Employees
142.00
Website
https://www.profoundmedical.comCEO
Arun Swarup Menawat MBA,
Description
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for magnetic resonance imaging scanner in hospitals and treatment facilities. The company also offers Sonalleve, a therapeutic platform for the treatment of uterine fibroids and palliative pain relief associated with metastases in bone, as well as non-invasive treatment of uterine fibroids. Profound Medical Corp. is headquartered in Mississauga, Canada.
PROF Financial Timeline
Browse a chronological timeline of Profound Medical Corp. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 May 2026
Upcoming earnings on 6 Nov 2025
EPS estimate is -$0.43, while revenue estimate is $6.56M.
Earnings released on 14 Aug 2025
EPS came in at -$0.52 falling short of the estimated -$0.43 by -20.93%, while revenue for the quarter reached $1.62M , missing expectations by -65.84%.
Earnings released on 8 May 2025
EPS came in at -$0.36 falling short of the estimated -$0.29 by -24.14%, while revenue for the quarter reached $1.83M , missing expectations by -60.94%.
Earnings released on 6 Mar 2025
EPS came in at -$0.20 surpassing the estimated -$0.31 by +35.48%, while revenue for the quarter reached $2.57M , missing expectations by -56.50%.
Earnings released on 7 Nov 2024
EPS came in at -$0.38 falling short of the estimated -$0.33 by -15.15%, while revenue for the quarter reached $2.09M , missing expectations by -64.23%.
Earnings released on 8 Aug 2024
EPS came in at -$0.28 matching the estimated -$0.28, while revenue for the quarter reached $1.63M , missing expectations by -36.94%.
Earnings released on 9 May 2024
EPS came in at -$0.26 surpassing the estimated -$0.31 by +16.13%, while revenue for the quarter reached $1.41M , missing expectations by -44.19%.
Earnings released on 7 Mar 2024
EPS came in at -$0.42 falling short of the estimated -$0.28 by -50.00%, while revenue for the quarter reached $1.51M , missing expectations by -22.43%.
Earnings released on 2 Nov 2023
EPS came in at -$0.26 surpassing the estimated -$0.32 by +18.75%, while revenue for the quarter reached $1.28M , missing expectations by -36.84%.
Earnings released on 9 Aug 2023
EPS came in at -$0.35 falling short of the estimated -$0.31 by -12.90%, while revenue for the quarter reached $1.21M , missing expectations by -44.27%.
Earnings released on 10 May 2023
EPS came in at -$0.32 surpassing the estimated -$0.38 by +15.79%, while revenue for the quarter reached $1.37M , missing expectations by -34.85%.
Earnings released on 7 Mar 2023
EPS came in at -$0.46 falling short of the estimated $0.36 by -227.78%, while revenue for the quarter reached $936.81K , missing expectations by -64.95%.
Earnings released on 3 Nov 2022
EPS came in at -$0.24 surpassing the estimated -$0.34 by +29.41%, while revenue for the quarter reached $1.49M , missing expectations by -38.45%.
Earnings released on 4 Aug 2022
EPS came in at -$0.28 surpassing the estimated -$0.42 by +33.33%, while revenue for the quarter reached $1.57M , missing expectations by -22.01%.
Earnings released on 9 May 2022
EPS came in at -$0.40 surpassing the estimated -$0.45 by +11.11%, while revenue for the quarter reached $1.09M , missing expectations by -37.88%.
Earnings released on 3 Mar 2022
EPS came in at -$0.49 falling short of the estimated -$0.35 by -40.00%, while revenue for the quarter reached $782.66K , missing expectations by -71.94%.
Earnings released on 4 Nov 2021
EPS came in at -$0.29 falling short of the estimated -$0.26 by -11.54%, while revenue for the quarter reached $2.00M , missing expectations by -10.83%.
Earnings released on 4 Aug 2021
EPS came in at -$0.35 falling short of the estimated -$0.26 by -34.62%, while revenue for the quarter reached $2.12M , missing expectations by -17.74%.
Earnings released on 12 May 2021
EPS came in at -$0.37 falling short of the estimated -$0.24 by -54.17%, while revenue for the quarter reached $565.68K , missing expectations by -15.76%.
Earnings released on 2 Mar 2021
EPS came in at -$0.38 falling short of the estimated -$0.27 by -40.74%, while revenue for the quarter reached $2.23M .
Earnings released on 5 Nov 2020
EPS came in at -$0.32 falling short of the estimated -$0.23 by -39.13%, while revenue for the quarter reached $1.67M , missing expectations by -27.26%.
PROF Stock Performance
Access detailed PROF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.